Scotland: Newborns now screened for rare muscle-wasting disease

Scotland has achieved a significant public health milestone by becoming the first region in the UK to implement routine screening for spinal muscular atrophy (SMA) in newborns. This initiative, launched recently, aims to detect the condition early through the existing blood spot test administered to babies shortly after birth.

SMA is a rare genetic disorder that leads to progressive muscle weakness, breathing difficulties, and mobility loss. Early diagnosis and treatment are critical to mitigating the most severe effects and preventing irreversible nerve damage. Previously, many children were diagnosed too late, resulting in lifelong disabilities.

The screening program is a direct result of dedicated campaigning, including efforts by parents and public figures like Jesy Nelson, whose own children have SMA. The initiative is supported by The Mirror's campaign for nationwide testing.

This two-year pilot is funded through a collaboration between the Scottish Government, contributing £95,000, and the pharmaceutical company Novartis, providing £435,000. Experts anticipate that this proactive approach will significantly improve the quality of life for affected children, allowing them to receive timely treatment before symptoms manifest.